GPT Healthcare IPO: The preliminary public providing (IPO) of GPT Healthcare Limited hit the Indian major market on twenty second February 2024 i.e. on Thursday final week. the general public situation will stay open until twenty sixth February 2024 i.e. until Monday subsequent week. The mid-sized multi-specialty lodge firm has mounted the problem value at ₹177 to ₹186 per fairness share. As per the GPT Healthcare IPO subscription status, the general public situation has been subscribed 0.85 occasions in first two days of bidding.

Meanwhile, after two days of bidding, shares of GPT Healthcare Limited can be found at a premium of ₹13 within the gray market at the moment, say stock market observers.

As per the inventory market observers, GPT Healthcare IPO GMP (gray market premium) at the moment is ₹13, which is larger from the problem opening date. On Thursday, GPT Healthcare IPO GMP was zero. So, in two days, the gray market sentiments have improved relating to GPT Healthcare IPO. Market observers stated that enchancment within the gray market sentiment could be attributed to pattern reversal on Dalal Street becuase the general public situation has obtained boring response from the first market traders in first two days of bidding.

After two days of bidding, the e book construct situation obtained subscribed 0.85 occasions whereas the retail portion of the general public situation has been booked 1.25 occasions. The NII phase of the general public situation has been booked 0.79 occasions whereas QIB portion obtained subscribed 0.19 occasions.

The situation obtained bids of 1,67,75,440 shares towards the provided 1,97,63,327 fairness shares, at a value band of ₹177 to ₹186, in keeping with the information out there on the inventory exchanges.

Leading brokerage companies like Reliance Securities, Nirmal Bang, Anand Rathi, Mehta Equities and SMIFS have given a “Subscribe” ranking to GPT Healthcare Ltd, given its sturdy positioning in underserved and populous healthcare supply markets. Company’s ‘Right-sized’, full service and strategically positioned hospitals have led to excessive return on capital. Its nicely diversified specialty combine, location combine and talent to draw, practice and retain high quality medical professionals are different key positives as per the brokerage companies.

Giving ‘subscribe’ tag to the general public situation, Anand Rathi stated, “GPT Healthcare operates a chain of mid-sized full-service hospitals under the same brand and provides integrated healthcare services, with a focus on secondary and tertiary care. Going ahead, the company intends to strengthen its existing hospitals by further balancing specialty mix, deepening its expertise in selective specialties and adding new specialties and services. At the upper price band company is valuing at P/E of 39.1x with a market cap of ₹15,262 million post issue of equity shares and return on net worth of 23.7% in FY23. On the valuation front, we believe that the company is fairly priced. Thus, we recommend an “Subscribe – Long Term” ranking to the IPO.”

Advising traders to use for the long-term, Mahesh M Ojha, AVP — Research & Business Development at Hensex Securities stated, “GPT Healthcare key regional corporate healthcare company with a strong foothold in under-penetrated and densely populated healthcare delivery market, Well diversified specialty mix and location mix, Ability to attract, train and retain quality medical professionals, However, The healthcare delivery market in India is expected to grow at a CAGR of 9%-11% between Fiscal Years 2024 and 2028 and reach ₹ 9.2-9.3 trillion in Fiscal Year 2028. We suggest a ‘Subscribe’ to the issue with long term investment perspective.”

Disclaimer: The views and suggestions above are these of particular person analysts, consultants, and broking firms, not of Mint. We advise traders to test with licensed consultants earlier than making any funding choices.